International Guidelines for the Selection of Lung Transplant Candidates: 2006 Update—A Consensus Report From the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Maurer, 1998, International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society, J Heart Lung Transplant, 17, 703
Trulock, 2005, Registry of the International Society for Heart and Lung Transplantation, J Heart Lung Transplant, 24, 956, 10.1016/j.healun.2005.05.019
Boucek, 2005, Registry of the International Society for Heart and Lung Transplantation, J Heart Lung Transplant, 24, 968, 10.1016/j.healun.2005.05.020
Charman, 2002, Assessment of survival benefit after lung transplantation by patient diagnosis, J Heart Lung Transplant, 21, 226, 10.1016/S1053-2498(01)00352-7
Demeester, 2001, Listing for lung transplantation, J Heart Lung Transplant, 20, 518, 10.1016/S1053-2498(01)00241-8
Thabut, 2003, Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis, J Thorac Cardiovasc Surg, 126, 469, 10.1016/S0022-5223(03)00600-7
Geertsma, 1998, Does lung transplantation prolong life? A comparison of survival with and without transplantation, J Heart Lung Transplant, 17, 511
Hosenpud, 1998, Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease, Lancet, 351, 24, 10.1016/S0140-6736(97)06405-2
Gerbase, 2005, Health-related quality of life following single or bilateral lung transplantation, Chest, 128, 1371, 10.1378/chest.128.3.1371
Gross, 1995, Long-term health status and quality-of-life outcomes of lung transplant recipients, Chest, 108, 1587, 10.1378/chest.108.6.1587
Maish, 2002, Priorities for lung transplantation among patients with cystic fibrosis, JAMA, 287, 1524
Kanasky, 2002, Impact of body weight on long-term survival after lung transplantation, Chest, 121, 401, 10.1378/chest.121.2.401
Parekh, 2005, Outcome of lung transplantation for patients requiring concomitant cardiac surgery, J Thorac Cardiovasc Surg, 130, 859, 10.1016/j.jtcvs.2005.05.004
Connors, 1996, Outcomes following acute exacerbation of severe chronic obstructive lung disease, Am J Respir Crit Care Med, 154, 959, 10.1164/ajrccm.154.4.8887592
Oga, 2003, Analysis of the factors related to mortality in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 167, 544, 10.1164/rccm.200206-583OC
Celli, 2004, The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease, N Engl J Med, 350, 1005, 10.1056/NEJMoa021322
Fishman, 2003, A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema, N Engl J Med, 348, 2059, 10.1056/NEJMoa030287
Egan, 2001, Predictors of death on the UNOS lung transplant waiting list, J Heart Lung Transplant, 20, 242, 10.1016/S1053-2498(00)00547-7
2006, 2003 annual report of the US Organ Procurement and Transplantation Network
Egan, 2002, Long-term results of lung transplantation for cystic fibrosis, Eur J Cardiothorac Surg, 22, 602, 10.1016/S1010-7940(02)00376-7
Liou, 2001, Survival effect of lung transplantation among patients with cystic fibrosis, JAMA, 286, 2683, 10.1001/jama.286.21.2683
De Soyza, 2003, Pulmonary transplantation for cystic fibrosis, J Heart Lung Transplant, 22, 764, 10.1016/S1053-2498(02)00641-1
Aris, 1997, The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome, Am J Respir Crit Care Med, 155, 1699, 10.1164/ajrccm.155.5.9154879
Dobbin, 2004, The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis, J Hosp Infect, 56, 277, 10.1016/j.jhin.2004.01.003
Chaparro, 2001, Infection with Burkholderia cepacia in cystic fibrosis, Am J Respir Crit Care Med, 163, 43, 10.1164/ajrccm.163.1.9811076
Aris, 2001, Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type, Am J Respir Crit Care Med, 164, 2102, 10.1164/ajrccm.164.11.2107022
Liou, 2005, Use of lung transplantation survival models to refine patient selection in cystic fibrosis, Am J Respir Crit Care Med, 171, 1053, 10.1164/rccm.200407-900OC
De Soyza, 2001, Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis, Lancet, 358, 1780, 10.1016/S0140-6736(01)06808-8
Levine, 2004, A survey of clinical practice of lung transplantation in North America, Chest, 125, 1224, 10.1378/chest.125.4.1224
McMenamin, 2000, Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers, Chest, 117, 1661, 10.1378/chest.117.6.1661
Klima, 1997, Successful lung transplantation in spite of cystic fibrosis-associated liver disease, J Heart Lung Transplant, 16, 934
Flume, 1994, Lung transplantation for mechanically ventilated patients, J Heart Lung Transplant, 13, 15
Bartz, 2003, Pre-transplant mechanical ventilation and outcome in patients with cystic fibrosis, J Heart Lung Transplant, 22, 433, 10.1016/S1053-2498(02)00667-8
Egan, 2003, Risk factors for death after lung transplant in the U.S, J Heart Lung Transplant, 22, S146, 10.1016/S1053-2498(02)00920-8
Kerem, 1992, Prediction of mortality in patients with cystic fibrosis, N Engl J Med, 326, 1187, 10.1056/NEJM199204303261804
Liou, 2001, Predictive 5-year survivorship model of cystic fibrosis, Am J Epidemiol, 153, 345, 10.1093/aje/153.4.345
Augarten, 2001, Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients, Pediatr Transplant, 5, 339, 10.1034/j.1399-3046.2001.00019.x
Mayer-Hamblett, 2002, Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality, Am J Respir Crit Care Med, 166, 1550, 10.1164/rccm.200202-087OC
Hayllar, 1997, A prognostic model for the prediction of survival in cystic fibrosis, Thorax, 52, 313, 10.1136/thx.52.4.313
Sharma, 2001, Wasting as an independent predictor of mortality in patients with cystic fibrosis, Thorax, 56, 746, 10.1136/thorax.56.10.746
Ellaffi, 2005, One-year outcome after severe pulmonary exacerbation in adults with cystic fibrosis, Am J Respir Crit Care Med, 171, 158, 10.1164/rccm.200405-667OC
Rosenbluth, 2004, Lung function decline in cystic fibrosis patients and timing for lung transplantation referral, Chest, 126, 412, 10.1378/chest.126.2.412
Davis, 1999, The gender gap in cystic fibrosis survival, J Gend Specif Med, 2, 47
Venuta, 2000, Pulmonary hemodynamics contribute to indicate priority for lung transplantation in patients with cystic fibrosis, J Thorac Cardiovasc Surg, 119, 682, 10.1016/S0022-5223(00)70002-X
Flaherty, 2001, Histopathologic variability in usual and nonspecific interstitial pneumonias, Am J Respir Crit Care Med, 164, 1722, 10.1164/ajrccm.164.9.2103074
Monaghan, 2004, Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias, Chest, 125, 522, 10.1378/chest.125.2.522
Flaherty, 2002, Clinical significance of histological classification of idiopathic interstitial pneumonia, Eur Respir J, 19, 275, 10.1183/09031936.02.00182002
Katzenstein, 1994, Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance, Am J Surg Pathol, 18, 136, 10.1097/00000478-199402000-00003
Travis, 2000, Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia, Am J Surg Pathol, 24, 19, 10.1097/00000478-200001000-00003
Latsi, 2003, Fibrotic idiopathic interstitial pneumonia, Am J Respir Crit Care Med, 168, 531, 10.1164/rccm.200210-1245OC
Jegal, 2005, Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia, Am J Respir Crit Care Med, 171, 639, 10.1164/rccm.200403-331OC
Alhamad, 2001, Pulmonary function tests in interstitial lung disease, Clin Chest Med, 22, 715, 10.1016/S0272-5231(05)70062-9
King, 2005, Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis, Chest, 127, 171, 10.1378/chest.127.1.171
Flaherty, 2003, Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia, Am J Respir Crit Care Med, 168, 543, 10.1164/rccm.200209-1112OC
Collard, 2003, Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 168, 538, 10.1164/rccm.200211-1311OC
Martinez, 2005, The clinical course of patients with idiopathic pulmonary fibrosis, Ann Intern Med, 142, 963, 10.7326/0003-4819-142-12_Part_1-200506210-00005
Collard, 2003, Demystifying idiopathic interstitial pneumonia, Arch Intern Med, 163, 17, 10.1001/archinte.163.1.17
Mogulkoc, 2001, Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation, Am J Respir Crit Care Med, 164, 103, 10.1164/ajrccm.164.1.2007077
Fartoukh, 2000, Severe pulmonary hypertension in histiocytosis X, Am J Respir Crit Care Med, 161, 216, 10.1164/ajrccm.161.1.9807024
Erbes, 1997, Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome?, Chest, 111, 51, 10.1378/chest.111.1.51
Miki, 2003, Impairments and prognostic factors for survival in patients with idiopathic pulmonary fibrosis, Respir Med, 97, 482, 10.1053/rmed.2002.1469
Gay, 1998, Idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 157, 1063, 10.1164/ajrccm.157.4.9703022
Lama, 2003, Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia, Am J Respir Crit Care Med, 168, 1084, 10.1164/rccm.200302-219OC
Douglas, 2000, Idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 161, 1172, 10.1164/ajrccm.161.4.9907002
Raghu, 2004, A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis, N Engl J Med, 350, 125, 10.1056/NEJMoa030511
Morgan, 2003, Predictors of end stage lung disease in a cohort of patients with scleroderma, Ann Rheum Dis, 62, 146, 10.1136/ard.62.2.146
Steen, 1994, Severe restrictive lung disease in systemic sclerosis, Arthritis Rheum, 37, 1283, 10.1002/art.1780370903
Rosas, 2000, Lung transplantation and systemic sclerosis, Ann Transplant, 5, 38
D’Alonzo, 1991, Survival in patients with primary pulmonary hypertension. Results from a national prospective registry, Ann Intern Med, 115, 343, 10.7326/0003-4819-115-5-343
Hopkins, 1996, Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome, J Heart Lung Transplant, 15, 100
Badesch, 2000, Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial, Ann Intern Med, 132, 425, 10.7326/0003-4819-132-6-200003210-00002
Kawut, 2003, Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis, Chest, 123, 344, 10.1378/chest.123.2.344
Miyamoto, 2000, Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing, Am J Respir Crit Care Med, 161, 487, 10.1164/ajrccm.161.2.9906015
Sitbon, 2002, Long-term intravenous epoprostenol infusion in primary pulmonary hypertension, J Am Coll Cardiol, 40, 780, 10.1016/S0735-1097(02)02012-0
McLaughlin, 2002, Survival in primary pulmonary hypertension, Circulation, 106, 1477, 10.1161/01.CIR.0000029100.82385.58
Wensel, 2002, Assessment of survival in patients with primary pulmonary hypertension, Circulation, 106, 319, 10.1161/01.CIR.0000022687.18568.2A
Shorr, 2002, Outcomes for patients with sarcoidosis awaiting lung transplantation, Chest, 122, 233, 10.1378/chest.122.1.233
Arcasoy, 2001, Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation, Chest, 120, 873, 10.1378/chest.120.3.873
Shorr, 2005, Pulmonary hypertension in advanced sarcoidosis, Eur Respir J, 25, 783, 10.1183/09031936.05.00083404
Kitaichi, 1995, Pulmonary lymphangioleiomyomatosis, Am J Respir Crit Care Med, 151, 527, 10.1164/ajrccm.151.2.7842216
Taylor, 1990, Lymphangioleiomyomatosis. Clinical course in 32 patients, N Engl J Med, 323, 1254, 10.1056/NEJM199011013231807
Johnson, 1999, Decline in lung function in lymphangioleiomyomatosis, Am J Respir Crit Care Med, 160, 628, 10.1164/ajrccm.160.2.9901027
Boehler, 1996, Lung transplantation for lymphangioleiomyomatosis, N Engl J Med, 335, 1275, 10.1056/NEJM199610243351704
Delobbe, 1996, Determinants of survival in pulmonary Langerhans’ cell granulomatosis (histiocytosis X), Eur Respir J, 9, 2002, 10.1183/09031936.96.09102002